J&J’s Goggins Takes Bullet for CEO Weldon
The New York Times reports that Colleen A. Goggins, who testified this spring before a Congressional committee investigating the recalls, will retire in March....
Eli Lilly’s LillyPad Blog: To Whom Does It Speak?
Eli Lilly just joined the ranks -- more like single file -- of drug companies that have corporate blogs. Lilly calls their blog "LillyPad,"...
Pharma, Facebook, and Inappropriate Ads
The following tweet from Boehringer Ingelheim (BI) was posted to the "News Direct from Drug Industry" forum on Pharma Marketing Network:
Boehringer: Thank you. RT...
Is Pharma Really “Listening” to Patients on Social Media?
After criticizing Astrazeneca's @AZHelps Twitter account as being a poor model for use of social media by the pharmaceutical industry (see @AZHelps: Is This...
@AZHelps: Is This a Good Model for Pharma Use of Social Media?
Recently, @jilliantate (Jullian Tate), Director, digital strategy, for Integrated Media Solutions in Los Angeles, and someone I follow on Twitter, tweeted this:
"Wow. Great article...
Will Avandia Failure Lead to More Closely Supervised Clinical Studies and Longer Patent Life...
In a BMJ editorial, editor Fiona Godlee contends that Avandia "should not have been licensed and should now be withdrawn." She cites problems that...
My Journey From Obesity to Normal. First Stop: Stuck in Overweight!
Because of the long holiday weekend looming here in the U.S., I anticipate that today will be pretty slow. Therefore, it's a good time...
“Reasonable” $600 MILLION Fine for Misbranding BOTOX: I Guess Allergan’s Suit Against FDA Paid...
Allergan -- the company that markets Botox legally for wrinkles and illegally for other things -- agreed to pay $600 million in fines,...
Pharma Email Spam: Three Degrees of Separation for Merck, Pfizer, and Genentech
Soon after I posted a blog entry and tweeted about cholesterol-lowering drugs (see here), I "coincidentally" received the following e-mail message (click for an...
Until All of Us Have This “Blue Button,” the Online Health Revolution Has Not...
Today I will listen to the BlogTalkRadio show "E-patients, Cyberchondriacs, and Why We Should Stop Calling Names," which promises to be an "open, honest...
